Medical Weight Loss for Hoboken, New Jersey Residents

Hoboken, New Jersey residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Hoboken through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

No clinic to drive to in Hoboken: Dr. Anjmun Sharma reviews your health by video, and your compounded semaglutide or tirzepatide ships straight to your New Jersey address. Nothing to pick up, no waiting room, no local office needed. Doctor review just $119 (medication separate).

Why Hoboken Residents Choose New Hope Weight Loss

Some patients in Hoboken are weighing semaglutide against tirzepatide, and that is a conversation worth having with a doctor, not a website. Dr. Anjmun Sharma helps you understand the trade-offs, the cost difference between $166 and $233 a month, and what the trial data actually showed, with semaglutide averaging about 15 to 17 percent body-weight loss and tirzepatide reaching up to 22.5 percent at qualifying doses. These are compounded, not brand-identical, and results vary, so the choice should be informed.

Hoboken patients are cared for entirely through telehealth from our Costa Mesa, California clinic. There is no travel, your consultation with Dr. Sharma, prescription, and follow-ups all happen by secure video.

Patients in Hoboken get the identical physician-supervised treatment that someone walking into our Costa Mesa office would get, all of it handled by telehealth so New Jersey residents never have to travel. We care for patients throughout Hoboken and the Hudson County waterfront across from Manhattan. Your semaglutide or tirzepatide travels in insulated cold-pack packaging to keep it stable on the way to Hoboken, even on warm New Jersey afternoons.

Treatment is supervised by the same physician for all of New Jersey, which means your distance from Costa Mesa changes nothing about your care or your cost. Getting started in Hoboken is simple: a New Jersey licensed physician reviews your health history for $119, and your medication is billed separately if you are approved. New Jersey is one of the most densely populated states in the country, and New Hope Weight Loss serves patients across it by telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Compounded GLP-1 care, supervised by a physician

The 90-Day Metabolic Reset is built on semaglutide, the same active ingredient you will find in Wegovy and Ozempic. It is priced from $166/mo, with the complete 90-day program at $499, and branded-drug trials averaged about 15 to 17 percent body-weight loss. Compounded semaglutide is not FDA-approved, not brand-identical, and results vary by person. Dr. Sharma manages your care by telehealth, wherever you are in Hoboken.

Prefer the dual-action route? Tirzepatide

From $233/mo, tirzepatide works on GLP-1 and GIP together. In branded-drug trials, dose-qualified patients reached up to 22.5 percent loss, a peak number that is not typical. Same active ingredient as Mounjaro and Zepbound.

It all starts with a $119 physician review. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Hoboken

Step 1. Complete the online intake and weight-history quiz from your phone or laptop.

Step 2. Dr. Sharma reviews everything and meets you over secure video, typically within 48 hours, to confirm whether compounded semaglutide or tirzepatide makes sense for you.

Step 3. If appropriate, a state-licensed 503(a) pharmacy ships your medication to your Hoboken home in insulated cold-pack packaging.

Step 4. You check in by video for follow-ups, so adjusting your dose never means a drive across .

Frequently Asked Questions, Hoboken

Does New Hope Weight Loss have a presence in Hoboken?

Our presence in Hoboken is through telehealth rather than a storefront. The clinic itself is in Costa Mesa, California, our sole physical location. We serve Hoboken, New Jersey patients online, and Dr. Anjmun Sharma confirms your eligibility for compounded semaglutide or tirzepatide during a private video consultation.

Could a Hoboken patient complete care without leaving home?

Yes, staying home is the norm. Everything for Hoboken patients runs over telehealth, including the initial consult, dose adjustments, and check-ins. After approval, your medication travels to Hoboken in insulated cold-pack shipping that protects it from temperature swings during delivery.

How are Hoboken patients charged?

There is a $119 fee for the physician review. Semaglutide starts at $166 monthly, with a 90-day option at $499, and tirzepatide at $233 monthly. The medication itself is a separate cost. We accept HSA, FSA, Klarna, and Affirm, and we add no distance surcharge for Hoboken.

What areas of Hoboken do you serve?

We serve patients from across Hoboken by telehealth, including Hoboken and the Hudson County waterfront across from Manhattan.

What does treatment cost for Hoboken patients?

The same flat pricing nationwide: a $119 physician visit, compounded semaglutide from $166/month, and compounded tirzepatide from $233/month, with medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, and there is no distance surcharge for Hoboken.

Hoboken Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Hoboken, New Jersey by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.